Journal My Health

Journal My Health The Journal My Health app helps people with chronic conditions tell their health stories to their health providers, for better health outcomes.

Available on iOS and Android.

Autoimmune issues and Perimenopause?  Start 2026 off right. Be a Project Eve Beta Testers!  We're almost full, but we ha...
12/02/2025

Autoimmune issues and Perimenopause? Start 2026 off right. Be a Project Eve Beta Testers!

We're almost full, but we have a few more spots for our pilot program.

Real talk: Why join as a beta tester?
1️⃣ You'll get insights you can't get anywhere else Our AI analyzes YOUR specific patterns to predict when flares are coming—sometimes days or weeks in advance. Imagine being able to plan around that.

2️⃣ You'll help shape something that doesn't exist yet A platform built BY women WITH autoimmune diseases and menopause, FOR women navigating this intersection. Your feedback directly influences what we build.

3️⃣ You'll be part of groundbreaking research Your anonymized data contributes to the first-ever large-scale study of autoimmune disease patterns during menopause. This is how we change the standard of care.

4️⃣ You'll find your people Connect with other women who truly understand what you're going through. No more explaining. Just support.

What we're asking: ✓ 3 months of symptom tracking (we make it quick—under 5 min/day) ✓ Optional surveys at months 1 and 3 ✓ Honest feedback about what works and what doesn't

Ready to help us change women's health?
Comment "INTERESTED" below or send us a DM for the application.

Gratitude is one of the most powerful forms of care. This Thanksgiving, we’re thankful for our community, the individual...
11/27/2025

Gratitude is one of the most powerful forms of care.

This Thanksgiving, we’re thankful for our community, the individuals who share their health journeys, the providers and researchers listening with intention and everyone working to make healthcare more compassionate and connected.

Taking time to rest, reflect and care for yourself is part of your wellness story too.

From all of us at Journal My Health, we wish you a healthy and peacefulThanksgiving.

New research confirms what many women have been experiencing but couldn't explain:Perimenopause is associated with incre...
11/25/2025

New research confirms what many women have been experiencing but couldn't explain:
Perimenopause is associated with increased risk of lymphocyte-mediated autoimmune diseases.
Studies show that around age 50, women experience a drop in neutrophil percentage while lymphocyte percentage rises—creating a perfect storm for autoimmune activation.

Even more striking: The incidence of lupus (SLE) peaks in women aged 40-49 (perimenopause), then drops sharply in the 50-59 age group. The female-to-male ratio shifts dramatically from 7:1-15:1 after puberty to 3:1-8:1 post-menopause.

This tells us that hormonal transitions—not just hormone levels—are critical players in autoimmune disease onset and activity.

Yet most women entering this transition don't know about this risk. Most doctors don't routinely screen for it. And there are few tools to help predict or prevent flares during this vulnerable window.

This research validates what Project Eve is designed to address: the need for predictive, personalized insights at this critical intersection.

When we can identify patterns BEFORE flares happen, we can intervene earlier. Adjust medications proactively. Make lifestyle changes that actually prevent crashes instead of just reacting to them.

This is what evidence-based, data-driven women's health looks like.

Be part of our Beta Test to learn how we can help you.

Sources:
• "Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan" (PMC)
• "The Impact of Menopause on Autoimmune and Rheumatic Diseases" (Clinical Reviews in Allergy & Immunology, 2025)

11/20/2025

"My rheumatologist focuses on my lupus. My OB/GYN focuses on my menopause symptoms. But nobody's talking about how they're affecting each other." This is what we hear from women every single day.

When you're managing an autoimmune condition and entering perimenopause, you're often caught between specialists who aren't communicating about YOUR whole experience.
• Your joints hurt more—is it your RA flaring, or is it the estrogen decline affecting joint lubrication?
• Your fatigue has deepened—is it your Hashimoto's acting up, or menopause-related sleep disruption spiking your cortisol?
• Your brain fog is worse—is it lupus affecting your cognition, or hormonal changes impacting neurotransmitters?

The answer is usually: all of the above.

But without tracking the full picture—your symptoms, triggers, cycle patterns, sleep, stress, environment—it's nearly impossible to know what's driving what.

This is why Project Eve exists. To help you connect the dots.

To give you the data and insights to walk into your doctor's appointments and say: "Here's my pattern. Here's what I'm noticing. Here's what might be connected." Because you deserve care that sees ALL of you—not just separate parts.

Have you experienced this fragmentation in your care? Tell us about it.

There's a $50 billion market for women's health—yet women living with autoimmune diseases during menopause are largely i...
11/18/2025

There's a $50 billion market for women's health—yet women living with autoimmune diseases during menopause are largely invisible.

Here's the reality:
• 50 million Americans have autoimmune diseases
• 80% of them are women
• Women in perimenopause/menopause are at heightened risk for autoimmune activation due to hormonal shifts
• Yet there's almost NO personalized data or predictive tools for this massive overlap

The women's digital health market is projected to reach $12.9 billion by 2032, growing at 19.7% annually. Meanwhile, autoimmune diseases cost the U.S. healthcare system $70+ billion per year for just 7 conditions.

But here's what's missing: Real-world data and predictive insights for women navigating BOTH menopause AND autoimmunity.

This is the gap Project Eve is designed to fill.

We're building the first platform that:
• Captures the unique experience of this intersection.
• Uses AI to predict flares before they happen.
• Gives women actionable insights to share with their doctors.
• Generates research data to accelerate discovery

The market opportunity is massive. But more importantly? Millions of women need this NOW.
Who else believes women's health deserves better data, better tools, and better outcomes?

We're Looking for Beta Testers! Are you a woman navigating perimenopause or menopause while managing an autoimmune condi...
11/13/2025

We're Looking for Beta Testers!
Are you a woman navigating perimenopause or menopause while managing an autoimmune condition?

We're launching Project Eve—the first digital platform designed specifically for women at this critical intersection—and we need YOUR voice to help shape it.

What is Project Eve? A personalized tracking platform that helps you:
✨ Predict autoimmune flares before they happen
✨ Identify your unique symptom patterns and triggers
✨ Make informed decisions about your health
✨ Share data with your healthcare team

Beta Program Benefits:
* FREE access to the platform (3-month pilot)
* Personalized flare predictions and analyses
* Direct input into product development
* Community of women who truly understand
* Contributing to groundbreaking research

Who We're Looking For:
✓ Women in perimenopause or menopause
✓ Living with or suspected autoimmune condition(s)
✓ Committed to tracking symptoms for 3 months
✓ Willing to share feedback

Limited spots available! We're starting with 25-50 women for our pilot.

Interested? Drop a "🙋‍♀️" in the comments or DM us for the application link.
Let's illuminate the path for women's health together.

Important new research from The Menopause Society's 2025 Annual Meeting: A study of nearly 1.8 million women found a sta...
11/11/2025

Important new research from The Menopause Society's 2025 Annual Meeting: A study of nearly 1.8 million women found a statistical link between hormone therapy and autoimmune disease risk.
While the absolute risk increase is relatively small and varies by condition, this highlights exactly why individualized care matters so much at the intersection of menopause and autoimmunity.

Key takeaway: Hormone therapy remains a safe and important option for many women when used appropriately but, like any treatment, it should be individualized.

This is precisely the challenge Project Eve aims to address—helping women and their clinicians make truly personalized decisions based on their unique symptom patterns, triggers, and risk profiles.

Because when it comes to managing autoimmune disease during menopause, one size definitely doesn't fit all.

Read the full research: https://ow.ly/lCZz50Xp0ox

11/06/2025

Did you know that 80% of autoimmune disease cases affect women—and that perimenopause can trigger or worsen symptoms in ways most doctors don't discuss?

For millions of women living with conditions like rheumatoid arthritis, lupus, Sjögren's syndrome, or Hashimoto's, the transition to menopause isn't just hot flashes and mood changes. It's unpredictable flares, deepening fatigue, and symptoms that suddenly become harder to manage.
Here's what's happening: As estrogen levels decline, your immune system becomes more dysregulated. Lower estrogen tips the body toward heightened inflammatory responses, even if your condition was stable before perimenopause.

The result? One week your body is calm, the next it's launching an inflammatory attack.
Yet most conventional care doesn't prepare women for this intersection. You're left wondering why your joints suddenly hurt more, your brain fog has intensified, or your medication doesn't seem to be working like it used to.

This is exactly why we're building Project Eve—to illuminate this critical gap in women's health.
If this resonates with you, share your experience in the comments. You're not alone.

Women's health is a huge, undervalued market with major investment momentum, now projected to reach $66B by 2030. Advanc...
10/16/2025

Women's health is a huge, undervalued market with major investment momentum, now projected to reach $66B by 2030. Advances in biotech, AI, and diagnostics are finally addressing conditions like PCOS, endometriosis, and postpartum depression—which have been ignored and undertreated for decades. Investors and founders have a chance to shape the future of more precise, woman-first healthcare—and the time to act is now.

https://ow.ly/534g50XahBB

Let’s talk about the power of health tracking, inspired by a recent NYT article on 10 menopause myths. The article uncov...
09/17/2025

Let’s talk about the power of health tracking, inspired by a recent NYT article on 10 menopause myths. The article uncovers that menopause is not just about hot flashes—it can mean insomnia, mood swings, cognitive changes, joint discomfort, and much more. Yet, many individuals are unaware of the full spectrum of symptoms and might overlook issues that could be treated if properly recognized.

That’s why consistent health tracking—from monitoring sleep patterns to logging physical and emotional changes—is so essential. When we track our health, we gain personalized insights, spot subtle shifts, and approach our providers with clear data. This can lead to earlier interventions, tailored treatments, and ultimately, better well-being.

Whether it’s menopause, chronic conditions, or everyday wellness, don’t let myths or a lack of information keep you from prioritizing your health. Leverage technology, listen to your body, and advocate for care. The more we know about our own bodies, the more empowered we are to ask the right questions—and receive the support we deserve.

https://ow.ly/LMmr50WMqF5

We are proud to celebrate our founder and CEO, Tracey Welson-Rossman, who has been named one of the 2025 Dealmakers of t...
09/11/2025

We are proud to celebrate our founder and CEO, Tracey Welson-Rossman, who has been named one of the 2025 Dealmakers of the Year Honorees - Social Impact Investing by the Smart Business Dealmakers Conference.

Tracey’s leadership and vision have always centered on creating opportunities for women — whether through founding TechGirlz, co-founding Chariot Solutions, or now building Journal My Health to transform women’s healthcare with data-driven insights.

This recognition honors her tireless work to amplify women’s voices, close gaps in research, and create lasting impact in health and technology.

Congratulations, Tracey!

09/05/2025

Women’s health is often under-researched and under-heard.

Our founder, Tracey Welson-Rossman, knows this firsthand. During her own health journey, she experienced side effects tied to her menstrual cycle from a prescribed medication. When she raised it, she was told it was not part of the drug’s profile. Later, she learned other women had the same experience.

The issue wasn’t that it didn’t exist. It simply wasn’t studied.

This is why women’s voices must be part of research and care. Autoimmune issues, chronic conditions, reproductive health, and the unique ways medications affect women all point to one truth: women are not small men.

At Journal My Health, we believe women’s stories are data. By capturing and amplifying those experiences, we can help close research gaps, guide innovation, and improve care for all.

Address

Philadelphia, PA

Alerts

Be the first to know and let us send you an email when Journal My Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Journal My Health:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram